Approximately 12% of women will develop breast cancer by the age of 85. Of these women:
• 70% will have sporadic breast cancer • 15 -20% will have familial breast cancer • 5 -10%
will have a hereditary breast cancer syndrome
The goal of any risk assessment strategy is to stratify patients into categories. In the case of breast cancer these are:
The benefits of an accurate risk assessment include:
• Application of appropriate screening guidelines • Opportunity to discuss risk reducing strategies • Patients have time to think about and act on risk reducing strategies • Optimizes the use of medical resources by avoiding over/under screening and over/under treating There are different methods of risk assessment.
• Collection and interpretation of personal medical and family history Risk assessment models based on empiric data.
• Provide different types of risk information:
• Chance of developing breast cancer (Claus Model, Breast Cancer Risk Assessment Tool)
• Chance of having a mutation in a gene, which results in a predisposition to a hereditary breast cancer syndrome. (BRCAPRO)
